Current Development Stage: Hit-to-lead
CARB-X Investment: Initial investment of up to $3.2m with potential options payments up to $11.4m
Initial CARB-X Investment Date: September 1, 2019
Location: United States, New Jersey
Employees: 11-50
Investors 1
| Date | Name | Website |
| - | CARB-X | carb-x.org |
Mentions in press and media 1
| Date | Title | Description |
| 01.05.2024 | TAXIS Pharmaceuticals Announces $2.67 Million NIH Grant to Advance Research and Development of Combination Therapy to Combat Antibiotic-Resistant Pneumonia | TAXIS Pharmaceuticals TAXIS Pharmaceuticals' investigational efflux pump inhibitors have been shown to restore potency of FDA-approved antibiotics in animal studies. NORTH BRUNSWICK, N.J., May 1, 2024 /PRNewswire-PRWeb/ -- TAXIS Pharmaceuti... |